CD47, a key cell surface receptor, exhibits significant overexpression in tumor tissues, including PDAC, compared to non-tumor tissues, as revealed by TCGA database analysis using GEPIA (Fig. 1 A). This evidence concerns the gene CD177 and neoplasm.